Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector
US Application 60/137,126
Filed on 1999-05-28
Filed on 1999-05-28
IDENTIFICATION OF INHIBITORS OF THE HGF-MET uPA-PLASMIN NETWORK USING A NOVEL CELLULAR ASSAY
US Application 60/130,613
Filed on 1999-04-22
Filed on 1999-04-22
Peptides and Their Utility in Modulation of Behavior of Cells Expressing Alpha 3 Beta 1 Integrins
US Application 60/144,549
Filed on 1999-07-15
Filed on 1999-07-15
T20/DP178 And T21/DP107 Are Activators of Human Phagocyte Formyl Peptide Receptors
US Application 60/132,686
Filed on 1999-05-05
Filed on 1999-05-05
Method of Reversing Chemotherapeutic Drug Resistance in tumor or Cancer Cells Utilizing an Acidically-Modified Dominant Negative
US Application 60/138,864
Filed on 1999-06-11
Filed on 1999-06-11
Reduction of the Nonspecific Animal Toxicity of Immunotoxin by Mutat- ing the framework regions of the Fv to Lower the Isoelectic Point
US Application 60/249,805
Filed on 2000-11-17
Filed on 2000-11-17
IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY Affinity Improvement of scFVsr ab's w/higher affinity for Mesothelin
US Application 60/160,071
Filed on 1999-05-27
Filed on 1999-05-27
Leukocyte Derived Anti-Viral Factors
US Application 60/162,262
Filed on 1999-10-29
Filed on 1999-10-29
Vaccines for B Cell Malignancies
US Application 60/011,783
Filed on 1996-02-16
Filed on 1996-02-16
Cytotoxic Metal Chelators and Their Use
US Application 60/090,618
Filed on 1998-06-25
Filed on 1998-06-25